Oztop N., Demir S., Beyaz S., Tuzer O. C., Colakoglu B., Buyukozturk S., ...More
ASTIM ALLERJI IMMUNOLOJI, vol.20, no.1, pp.36-47, 2022 (ESCI)
-
Publication Type:
Article / Article
-
Volume:
20
Issue:
1
-
Publication Date:
2022
-
Doi Number:
10.21911/aai.647
-
Journal Name:
ASTIM ALLERJI IMMUNOLOJI
-
Journal Indexes:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.36-47
-
Keywords:
Anaphylaxis, ABPA, severe asthma, chronic spontaneous urticaria, mastocytosis, nasal polyposis, omalizumab, BRONCHOPULMONARY ASPERGILLOSIS, ASTHMA, GUIDELINE, THERAPY
-
Istanbul University Affiliated:
Yes
Abstract
Objective: To evaluate the clinical outcome of omalizumab in various diseases.